Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper
- PMID:26378135
- PMCID: PMC4570937
- DOI: 10.1093/jat/bkv073
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper
Abstract
In recent years, N-methoxybenzyl-methoxyphenylethylamine (NBOMe) derivatives, a class of designer hallucinogenic drugs, have become popular drugs of abuse. These drugs have been the cause of severe intoxications and even deaths. They act as 5-HT2A receptors agonists and have been reported to produce serotonin-like syndrome with bizarre behavior, severe agitation and seizures persisting for as long as 3 days. The most commonly reported derivatives are 25I-NBOMe, 25B-NBOMe and 25C-NBOMe, respectively 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine, N-(2-methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine. Like many low dose hallucinogenic drugs these compounds are often sold on blotter paper. Three different types of commercially available blotter papers reported to contain NBOMe derivatives were obtained. These blotter papers were screened using Direct Analysis in Real Time AccuTOF(TM) mass spectrometry followed by confirmation and quantification by high-performance liquid chromatography triple quadrapole mass spectrometry. The major drug present on each of the three blotter products was different, 25I-NBOMe, 25C-NBOMe or 25B-NBOMe. The blotter papers were also found to have minute amounts of two or three NBOMe derivative impurities of 25H-NBOMe, 25I-NBOMe, 25C-NBOMe, 25B-NBOMe and/or 25D-NBOMe.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Figures



Similar articles
- Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.Nisbet LA, Venson R, Wylie FM, Scott KS.Nisbet LA, et al.J Anal Toxicol. 2017 Jul 1;41(6):559-565. doi: 10.1093/jat/bkx053.J Anal Toxicol. 2017.PMID:28830123
- Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.Gatch MB, Dolan SB, Forster MJ.Gatch MB, et al.Behav Pharmacol. 2017 Aug;28(5):375-385. doi: 10.1097/FBP.0000000000000309.Behav Pharmacol. 2017.PMID:28537942Free PMC article.
- Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers.Lützen E, Holtkamp M, Stamme I, Schmid R, Sperling M, Pütz M, Karst U.Lützen E, et al.Drug Test Anal. 2020 Apr;12(4):465-471. doi: 10.1002/dta.2751. Epub 2020 Jan 28.Drug Test Anal. 2020.PMID:31846172
- Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A.Suzuki J, et al.Psychosomatics. 2015 Mar-Apr;56(2):129-39. doi: 10.1016/j.psym.2014.11.002. Epub 2014 Nov 6.Psychosomatics. 2015.PMID:25659919Free PMC article.Review.
- NBOMes-Highly Potent and Toxic Alternatives of LSD.Zawilska JB, Kacela M, Adamowicz P.Zawilska JB, et al.Front Neurosci. 2020 Feb 26;14:78. doi: 10.3389/fnins.2020.00078. eCollection 2020.Front Neurosci. 2020.PMID:32174803Free PMC article.Review.
Cited by
- Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes.Peace MR, Butler KE, Wolf CE, Poklis JL, Poklis A.Peace MR, et al.Front Pharmacol. 2016 Aug 29;7:279. doi: 10.3389/fphar.2016.00279. eCollection 2016.Front Pharmacol. 2016.PMID:27621706Free PMC article.
- A Retrospective Analysis of Chemical Constituents in Regulated and Unregulated E-Cigarette Liquids.Holt AK, Poklis JL, Peace MR.Holt AK, et al.Front Chem. 2021 Oct 28;9:752342. doi: 10.3389/fchem.2021.752342. eCollection 2021.Front Chem. 2021.PMID:34778207Free PMC article.
- Molecular and Medical Aspects of Psychedelics.Wojtas A, Gołembiowska K.Wojtas A, et al.Int J Mol Sci. 2023 Dec 23;25(1):241. doi: 10.3390/ijms25010241.Int J Mol Sci. 2023.PMID:38203411Free PMC article.Review.
- Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats-pharmacokinetics, effects on behaviour and thermoregulation.Syrová K, Šíchová K, Danda H, Lhotková E, Jorratt P, Pinterová-Leca N, Vejmola Č, Olejníková-Ladislavová L, Hájková K, Kuchař M, Horáček J, Páleníček T.Syrová K, et al.Front Pharmacol. 2023 Mar 9;14:1120419. doi: 10.3389/fphar.2023.1120419. eCollection 2023.Front Pharmacol. 2023.PMID:36969854Free PMC article.
- Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures.Cassiano LMG, Oliveira MDS, de Barros WA, de Fátima Â, Coimbra RS.Cassiano LMG, et al.Heliyon. 2023 Jun 28;9(7):e17720. doi: 10.1016/j.heliyon.2023.e17720. eCollection 2023 Jul.Heliyon. 2023.PMID:37449113Free PMC article.
References
- González-Maeso J., Weisstaub N.V., Zhou M., Chan P., Ivic L., Ang R. et al. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron, 53, 439–452. - PubMed
- Shulgin A.T., Carter M.F. (1975) Centrally active phenethylamines. Psychopharmacol Commun, 1, 93–98. - PubMed
- Shulgin A., Shulgin A. (1991) PIHKAL: A Chemical Love Story. Transform Press, Berkeley, CA.
- Heim R., Pertz H.H., Elz S. (2000) Partial 5-HT2A-receptor agonists of the phenylethanamine series: effect of a trifluoromethyl substituent. Archiv der Pharmazie – Pharmaceutical and Medicinal Chemistry, 333, 45.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources